retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial From to Metabolic Health: Why Is a Game-Changer retatrutide triple hormone receptor agonist
Description
SmitsMMTonneijckLMuskietMHAKramerMHHPouwelsPJWPieters-van den BosICet al
The benefits beyond weight loss are substantial and growing as more research emerges
Archives Physiology Biochem
These drugs show the potential to treat existing alcohol problems rather than avoiding problems before they start, so are inferior to upstream policies
It also works in the brain to curb food noise, and in the gut to slow stomach emptying
